
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus natural ability to replicate in and kill cancer cells. This modality is known as oncolytic viral immunotherapy. KaliVirs cutting-edge, next generation oncolytic viral immunotherapy programs combine technologies developed in-house and licensed from University of Pittsburghs world-class oncolytic virus and immunotherapy research programs
Kalivir immunotherapeutics operates in the Biotechnology research industry.
Kalivir immunotherapeutics's revenue is 11m - 100m
Kalivir immunotherapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.